Description

Oliclinomel №7-1000E Suspension for Infusions 1000 ml. №6

Ingredients:

Oliclinomel №7-1000E suspension for infusions 1000 ml. №6 contains a balanced mixture of amino acids, glucose, lipids, electrolytes, and vitamins essential for parenteral nutrition.

Dosage:

The dosage of Oliclinomel №7-1000E suspension for infusions 1000 ml. №6 should be determined by a healthcare professional based on the patient’s nutritional needs and clinical condition.

Indications:

Oliclinomel №7-1000E suspension for infusions 1000 ml. №6 is indicated for patients who require total parenteral nutrition when oral or enteral feeding is not possible or insufficient.

Contraindications:

Do not use Oliclinomel №7-1000E suspension for infusions 1000 ml. №6 in patients with hypersensitivity to any of the ingredients, severe liver failure, or severe coagulopathy.

Directions:

Oliclinomel №7-1000E suspension for infusions 1000 ml. №6 should be administered intravenously over a specific period as directed by a healthcare provider. Monitoring for any signs of complications is crucial during infusion.

Scientific Evidence:

Oliclinomel formulations have been extensively studied in clinical settings, demonstrating their efficacy in meeting the nutritional requirements of critically ill patients. Research published in the Journal of Parenteral and Enteral Nutrition has shown that Oliclinomel suspensions provide adequate macronutrients and micronutrients essential for maintaining optimal nutritional status in patients requiring parenteral nutrition.

Additional Information:

In comparative studies, Oliclinomel suspensions have shown similar effectiveness in supporting patient outcomes compared to other standard parenteral nutrition solutions. The balanced composition of Oliclinomel №7-1000E suspension for infusions 1000 ml. №6 makes it a suitable choice for a wide range of patients requiring intravenous nutritional support.

Pharmacological Effects: Oliclinomel acts by providing essential nutrients directly into the bloodstream, bypassing the digestive system. The amino acids, lipids, and glucose in the suspension are readily available for cellular metabolism, supporting tissue repair and energy production.

Clinical Trials: Clinical trials have demonstrated the safety and efficacy of Oliclinomel suspensions in various patient populations, including those with critical illness, malnutrition, and gastrointestinal disorders. These trials have highlighted the importance of individualized dosing and monitoring to optimize patient outcomes.